Is Honey Antibacterial? The Research, Explained
All honey has some antibacterial activity. The mechanism, however, differs sharply between regular honey and Mānuka honey, and that difference is what justifies Mānuka's price premium and clinical research record.
How regular honey is antibacterial
Most honeys' antibacterial activity comes from hydrogen peroxide, produced when bees add the enzyme glucose oxidase to nectar. The hydrogen peroxide is potent in laboratory tests but unstable in real-world conditions: it degrades in light, in heat, when the honey is diluted, and on contact with the enzyme catalase (present in human tissue and stomach acid).
The practical implication: regular honey's antibacterial action is largely lost by the time the honey is consumed or applied to skin in clinical conditions.
How Mānuka honey is antibacterial
Mānuka honey has a second mechanism that does not depend on hydrogen peroxide. Mavric et al. (2008) identified the principal compound as methylglyoxal (MGO), which is heat-stable, light-stable, and survives the addition of catalase. Adams et al. (2009) traced the origin of MGO in Mānuka honey to dihydroxyacetone (DHA) in the nectar of the Mānuka flower, which converts to MGO during the 12-18 months of honey maturation.
The activity that does not depend on hydrogen peroxide is called Non-Peroxide Activity (NPA). NPA is what UMF (Unique Mānuka Factor) certification measures. See our NPA explainer for the full mechanism and grading.
What the laboratory research shows
Carter et al. (2016, Frontiers in Microbiology) summarized the laboratory evidence for Mānuka honey against bacterial pathogens. The activity is broad-spectrum: Mānuka honey has shown antibacterial effect against MRSA, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and others, in vitro.
Sherlock et al. (2010, BMC Complementary & Alternative Medicine) compared Mānuka with another high-activity honey (Ulmo from Chile) and found comparable activity against MRSA, suggesting the mechanism is shared across high-MGO honeys regardless of geography.
The translation gap
Laboratory antibacterial activity does not automatically translate to clinical efficacy in humans. Most rigorous human trials are in topical wound applications (see our wound-care research review). Claims about systemic effects (drinking honey to fight infection, for example) are not well-supported by human research, and stomach acid further degrades antibacterial compounds.
What this means for buyers
If you are paying a premium for Mānuka honey because of its antibacterial reputation, the relevant question is whether the jar carries verified MGO or NPA content:
- UMFHA-certified or MGO-rated jars have been tested for antibacterial markers.
- Mānuka without UMF or MGO labelling has not been antibacterial-tested and may be no different from regular honey on this metric.
- Higher MGO content correlates with stronger laboratory activity. UMF 10+ ≈ MGO 263; UMF 20+ ≈ MGO 829.
See our tested-and-ranked Mānuka roundup for currently available high-MGO options.
Sources
- Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Leptospermum scoparium (Mānuka) honeys from New Zealand. Molecular Nutrition & Food Research. 2008;52(4):483-9.
- Adams CJ, Manley-Harris M, Molan PC. The origin of methylglyoxal in New Zealand Mānuka (Leptospermum scoparium) honey. Carbohydrate Research. 2009;344(8):1050-3.
- Carter DA, Blair SE, Cokcetin NN, Bouzo D, Brooks P, Schothauer R, Harry EJ. Therapeutic Mānuka Honey: No Longer So Alternative. Frontiers in Microbiology. 2016;7:569.
- Sherlock O, Dolan A, Athman R, et al. Comparison of the antimicrobial activity of Ulmo honey from Chile and Mānuka honey against methicillin-resistant Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. BMC Complementary and Alternative Medicine. 2010;10:47.